Abstract
Platelets are born from megakaryocytes and are bred to adhere. As such, these anuclear particles represent one of the most highly specialized cells within the body. This functional dedication to adhesion is essential in order to prevent excessive bleeding from sites of vascular injury. The rapidity with which platelets seal an injured vessel is a remarkable testament to their adhesive specialization and is essential to the maintenance and/or restoration of vascular integrity. As with many physiologic systems, an overly exuberant cellular response can have major pathophysiologic consequences. In the case of platelet adhesion, the out-of-control response can be devastating, thrombosis, leading to life-threatening or debilitating pathologies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marcus AJ, Safier LB, Broekman MJ, et al. Thrombosis and inflammation as multicellular processes. Significance of cell-cell interactions. Thromb Haemost 1995;74:213–217.
Marcus AJ, Broekman MJ, Drosopoulos JHF, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997;99:1351–1360.
Bombeli T, Mueller M, Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997;77:408–423.
Ill CR, Engvall E, Ruoslahti E. Adhesion of platelets to laminin in the absence of activation. J Cell Biol 1985;99:2140–2145.
Grinnell F, Hays DG. Cell adhesion and spreading factor. Similarity to cold insoluble globulin in human serum. Exp Cell Res 1978;115:221–229.
Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 1979;279:636–638.
Leytin VL, Gorbunova NA, Misselwitz F, Novikov ID, Podrez EA, Plyusch OP. Step-by-step analysis of adhesion of human platelets to a collagen-coated surface. Defect in initial attachment and spreading of platelets in von Willebrand’s disease. Thromb Res 1984;34:51–63.
Brass LF, Bensusan HB. The role of collagen quaternary structure in the platelet: collagen interaction. J Clin Invest 1974;54:1480–1487.
Stenberg PE, McEver R-P, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101: 880–886.
Niija K, Hodson E, Bader R, et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 1987;70:475–482.
Michelson AD, Adelman B, Barnard MR, Carroll E, Handin RI. Platelet storage results in a redistribution of glycoprotein lb molecules. Evidence for a large intraplatelet pool of glycoprotein Ib. J Clin Invest 1988;81:1734–1740.
Kehrel B. Platelet receptors for collagens. Platelets 1995;6:11–16.
Sixma JJ, van Zanten GH, Saelman EUM, et al. Platelet adhesion to collagen. Thromb Haemost 1995; 74:454–459.
Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), αvβ3 integrin, and GPIba. J Exp Med 1998;187:329–339.
Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the β2 integrin CD1lb/CD18. Blood 1996;88:146–157.
Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to αllbβ33 and stimulated by platelet-activating factor. J Clin Invest 1997;100:2085–2093.
Neri Serneri GG, Prisco D, Martini F, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806–1812.
Kirchhofer D, Riederer MA, Baumgartner HR. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood 1997;89: 1270–1278.
Ott J, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in natients with unstable angina. Circulation 1996;94:1239–1246.
Sixma JJ, de Groot PG. Platelet adhesion. Br J Haematol 1990;75:308–312.
Lopez-Fernandez M, Ginsberg MH, Ruggeri ZM, Batlle FJ, Zimmerman TS. Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets. Blood 1982;60:1132–1138.
Paul JI, Schwarzbauer JE, Tamkun JW, Hynes RO. Cell-type-specific fibronectin subunits generated by alternative splicing. J Biol Chem 1986;261:12,258–12,265.
Santoro SA, Cowan JF. Adsorption of von Willebrand factor by fibrillar collagen. Implications concerning the adhesion of platelets to collagen. Coll Relat Res 1982;2:31–43.
Engvall E, Ruoslahti E, Miller EJ. Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 1978;147:1584–1595.
Mumby SM, Raugi GJ, Bornstein P. Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J Cell Biol 1984;98:646–652.
Topol EJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001; 104:2641–2644.
Strony J, Beaudoin A, Brands D, Adelman B. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 1993;265:H1787–H1796.
Girma J-P, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood 1987;70:605–611.
Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88:1525–1541.
Lopez JA. The platelet glycoprotein lb-IX complex. Blood Coagul Fibrinolysis 1994;5:97–119.
Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand’s disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978;92:750–764.
Houdijk PM, Sixma JJ. Fibronectin in artery subendothelium is important for platelet adhesion. Blood 1985;65:698–604.
Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998;95:9524–9529.
Ni H, Denis CV, Subbarao S, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000;106:385–392.
Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins lb and IIb-IIIa. Blood 1987; 69:625–628.
Roth GJ. Developing relationships: arterial platelet adhesion, glycoprotein lb, and leucine-rich glycoproteins. Blood 1991;77:5–19.
Ruggeri ZM. Structure and function of von Willebrand factor: relationship to von Willebrand’s disease. Mayo Clin Proc 1991;66:847–861.
Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549–550.
Parise LV. The structure and function of platelet integrins. Curr Opin Cell Biol 1989;1:947–952.
Ruoslahti E. Integrins. J Clin Invest 1991;87:1–5.
Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11–25.
Ginsberg MH, Du X, O’Toole TE, Loftus JC, Plow EF. Platelet integrins. Thromb Haemost 1993;70: 87–93.
Shattil SJ, Ginsberg MH. Perspective series: cell adhesion in vascular biology. Integrin signaling in vascular biology. J Clin Invest 1997;100:S91–595.
Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000;275: 21,785–21,788.
Bray PF, Rosa J-P, Lingappa VR, Kan YW, McEver R-P, Shuman MA. Biogenesis ot tue platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins llb and lila. Proc Natl Acad Sci USA 1986;83:1480–1484.
Poncz M, Eisman R, Heidenreich R, et al. Structure of the platelet membrane glycoprotein lIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem 1987; 262:8476–8482.
Loftus JC, Plow EF, Frelinger AL, III, et al. Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci USA 1987;84:7114–7118.
Loftus JC, Plow EF, Jennings LK, Ginsberg MH. Alternative proteolytic processing of platelet membrane GPIIb. J Biol Chem 1988;263:11,025–11,028.
Xiong JP, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alphaV beta3. Science 2001;294:339–345.
Haas TA, Plow EF. The cytoplasmic domain of αIIbβ3: a ternary complex of the integrin α and β subunits and a divalent cation. J Biol Chem 1996;271:6017–6026.
Hughes PE, Diaz-Gonzalez F, Leong L, et al. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem 1996;271:6571–6574.
Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol 1994;6: 695–704.
Bennett JS, Chan C, Vilaire G, Mousa SA, DeGrado WF. Agonist-activated αvβ3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem 1997;272:8137–8140.
Byzova TV, Plow EF. Activation of α3β3 on vascular cells controls recognition of prothrombin. J Cell Biol 1998;143:2081–2092.
Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol 1998;8:359–364.
Hogg N, Leitinger B. Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1. J Leukoc Biol 2001;69:893–898.
Grossi IM, Hatfield JS, Fitzgerald LA, Newcombe M, Taylor JD, Honn KV. Role of tumor cell glycoproteins immunologically related to glycoproteins lb and llb/IIIa in tumor cell-platelet and tumor cellmatrix interactions. FASEB J 1988;2:2385–2395.
Boukerche H, Berthier-Vergnes O, Tabone E, Dore J-F, Leung LLK, McGregor JL. Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood 1989;74:658–663.
Honn KV, Chen YQ, Timar J, Onoda JM, et al. αIIbβ3 integrin expression and function in subpopulations of murine tumors. Exp Cell Res 1992;201:23–32.
Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968;61:46–52.
Karpatkin S, Pearlstein E, Ambrogio C, Coller BS. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 1988;81:1012–1019.
Plow EF, Loftus JC, Levin EG, Fair DS, Dixon D, Forsyth J, Ginsberg MH. Immunologic relationship between platelet membrane glycoprotein relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells. Proc Natl Acad Sci USA 1986;83: 6002–6006.
Fitzgerald LA, Steiner B, Rall SC Jr, Lo SS, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. J Biol Chem 1987;262:3936–3939.
Byzova TV, Rabbani R, D’ Souza S, Plow EF. Role of integrin αvβ3in vascular biology. Thromb Haemost 1998;80:726–734.
Phillips DR, Scarborough RM. Clinical pharmacology of eptifibatide. Am J Cardiol 1997;80:11B–20B.
Barrett JS, Murphy G, Peerlinck K, et al. Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Clin Pharmacol Ther 1994;56:377–388.
Lele M, Sajid M, Wajih N, Stouffer GA. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. Circulation 2001;104:582–587.
Tam SH, Sassoli PM, Jordan RE, Nakada MT. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and αvβ3 integrins. Circulation 1998; 98:1085–1091.
Lam SC, Plow EF, D’ Souza SE, Cheresh DA, Frelinger AL III, Ginsberg MH. Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem 1989;264:3742–3749.
Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991;77:75–83.
Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996;88:907–914.
Lawler J, Hynes RO. An integrin receptor on normal and thrombasthenic platelets that bind thrombospondin. Blood 1989;74:2022–2027.
Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood 1993;81:2827–2843.
Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin αv13 for angiogenesis. Science 1994;264:569–571.
Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of αvβ3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995;95:713–724.
Nurden AT, Didry D, Rosa JP. Molecular defects of platelets in Bernard-Soulier syndrome. Blood Cells 1983;9:333–258.
George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets within the vessel wall. N Engl J Med 1984;311:1084–1088.
Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987;70: 895–904.
Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest 1991;88:1568–1573.
Yuan Y, Dopheide SM, Ivanidis C, Salem HH, Jackson SP. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin αIIbβ3) in von Willebrand factor-induced signal transduction. J Biol Chem 1997;272:21,847–21,854.
Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8: 270–276.
Miyata S, Goto S, Federici AB, Ware J, Ruggeri ZM. Conformational changes in the Al domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibα. J Biol Chem 1996;271: 9046–9053.
Cruz MA, Handin RI, Wise RJ. The interaction of the von Willebrand factor-Al domain with platelet glycoprotein Ib/IX. J Biol Chem 1993;268:21,238–21,245.
Roth GJ, Titani K, Hoyer LW, Hickey MJ. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 1986;25:8357–8361.
Howard MA, Firkin BG. Ristocetin-a new tool in the investigation of platelet aggregation. Thromb Haemost 1971;26:362–369.
Read MS, Smith SV, Lamb MA, Brinkhous KM. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989;74:1031–1035.
Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992;13:100–105.
Denis C, Williams JA, Lu X, Meyer D, Baruch D. Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the αβ3 receptor. Blood 1993;82:3622–3630.
Kroll MH, Hellums JD, Guo Z, et al. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 1993;268:3520–3524.
Okumura T, Jamieson GA. Platelet glycocalicin: a single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res 1976;8:701–706.
Moroi M, Goetze A, Dubay E, Wu C, Hasitz M, Jamieson GA. Isolation of platelet glycocalicin by affinity chromatography on thrombin-sepharose. Thromb Res 1982;28:103–114.
Andrews RK, Shen Y, Gardiner EE, Dong JF, Lopez JA, Berndt MC. The glycoprotein lb-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999;82:357–364.
Lopez JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ. The alpha and beta chains of human platelet glycoprotein lb are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 1988;85:2135–2139.
Hickey MJ, Williams SA, Roth GJ. Human platelet glycoprotein IX: an adhesive prototype of leucinerich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci USA 1989;86:6773–6777.
Andrews RK, Fox JEB. Interaction of purified actin-binding protein with the platelet membrane glycoprotein lb-IX complex. J Biol Chem 1991;266:7144–7147.
Cunningham JG, Meyer SC, Fox JEB. The cytoplasmic domain of the α-subunit of glycoprotein (GP) Ib mediates attachment of the entire GP lb-IX complex to the cytoskeleton and regulates von Willebrand factor-induced changes in cell morphology. J Biol Chem 1996;271:11,581–11,587.
Steinberg MH, Kelton JG, Coller BS. Plasma glycocalicin: an aid in the classification of thrombocytopenic disorders. N Engl J Med 1987;317:1037–1042.
Modderman PW, Admiraal LG, Sonnenberg A, von Dem Borne AE. Glycoproteins V and lb-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992;267:364–369.
Ni H, Ramakrishnan V, Ruggeri ZM, Papalia JM, Phillips DR, Wagner DD. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 7-15-2001;98:368–373.
DeMarco L, Girolami A, Russell S, Ruggeri ZM. Interaction of asialo von Willebrand factor with glycoprotein Tb induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 1985;75:1198–1203.
Du X, Fox JE, Pei S. Identification of a binding sequence for the 14–3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ibα. J Biol Chem 1996;271:7362–7367.
Wardell MR, Reynolds CC, Berndt MC, Wallace RW, Fox JEB. Platelet glycoprotein lb is phosphorylated on serine-166 by cyclic AMP-dependent protein kinase. J Biol Chem 1989;264:15,656–15,661.
Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998;101:479–486.
Santoro SA. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986;46:913–920.
Tandon NN, Kralisz U, Jamieson GA. Identification of GPIV (CD36) as a primary receptor for plateletcollagen adhesion. J Biol Chem 1989;264:7576–7583.
Nakamura T, Jamieson GA, Okuma M, Kambayashi J, Tandon NN. Platelet adhesion to native type I collagen fibrils. Role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem 1998;273:4338–4344.
Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood 1996;88:2081–2092.
Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985;318:470–472.
Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 1993;82:491–496.
Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989;84:1440–1445.
Verkleij MW, Morton LF, Knight CG, de Groot P, Barnes MJ, Sixma JJ. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via α2β31 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces. Blood 1998;91:3308–3816.
Saelman EUM, Kehrel B, IIese KM, de Groot PG, Sixma JJ, Nieuwenhuis HK. Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood 1994;83:3240–3244.
Watson SP. Collagen receptor signaling in platelets and megakaryocytes. Thromb Haemost 1999;82: 365–376.
Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001;86:189–197.
Morton LF, Fitzsimmons CM, Rauterberg J, Barnes MJ. Platelet-reactive sites in collagen. Collagens I and III possess different aggregatory sites. Biochem J 1987;248:483–487.
Santoro SA, Walsh JJ, Staatz WD, Baranski KJ. Distinct determinants on collagen support α2β1 integrin-mediated platelet adhesion and platelet activation. Cell Regul 1991;2:905–913.
Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem J 1995;306: 337–344.
Saelman EUM, Nieuwenhuis HK, Hese KM, et al. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (α2β1-integrin). Blood 1994;83: 1244–1250.
Ginsberg MH, Forsyth J, Lightsey A, Chediak J, Plow EF. Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets. J Clin Invest 1983;71:619–624.
Karczewski J, Knudsen KA, Smith L, Murphy A, Rothman VL, Tuszynski GP. The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa. J Biol Chem 1989;264:21,322–21,326.
Ruggeri ZM, Bader R, DeMarco L. Glanzmann thrombasthenia. Deficient binding of von Willebrand factor to thrombin-stimulated platelets. Proc Natl Acad Sci USA 1982;79:6038–6041.
Hantgan RR. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism. Biochim Biophys Acta 1988;968:24–35.
Thiagarajan P, Kelley KL. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 1988;263:3035–3038.
Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isolation of the thrombospondin membrane receptor. J Clin Invest 1987;79:1054–1061.
Asch AS, Silbiger S, Heimer E, Nachman RL. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 1992;182:1208–1217.
Catimel B, Leung L, El Ghissasi H, Mercier N, McGregor J. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), hut not to the N-terminal heparin-binding region. Biochem J 1992;284:231–236.
Gao AG, Lindberg FP, Dimitry JM, Brown EJ, Frazier WA. Thrombospondin modulates αvα3 function through integrin-associated protein. J Cell Biol 1996;135:533–544.
Chung J, Gao AG, Frazier WA. Thrombospondin acts via integrin-associated protein to activate the platelet integrin αIIb,β3. J Biol Chem 1997;272:14,740–14,746.
Plow EF, McEver R-P, Coller BS, Woods VL, Marguerie GA, Ginsberg MH. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor and thrombospondin on thrombin-stimulated human platelets. Blood 1985;66:724–727.
Plow EF, Srouji AH, Meyer D, Marguerie G, Ginsberg MH. Evidence that three adhesive proteins interact with common recognition site on activated platelets. J Biol Chem 1984;259:5388–5391.
Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH. The effect of Arg-Gly-Aspcontaining peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985;82:8057–8061.
Hantgan RR, Endenburg SC, Cavero I, et al. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by arg-gly-asp and fibrinogen gamma-chain carboxy terminal peptides. Thromb Haemost 1992;68:694–700.
Cherny RC, Honan MA, Thiagarajan P. Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem 1993;268:9725–9729.
Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffmann T. Fibrinogen-independent platelet adhesion and thrombus formation of subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest 1989;83:288–297.
Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot PG. Glycoprotein lb, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 1990;76:345–353.
Agbanyo FR, Sixma JJ, de Groot PG, Languino LR, Plow EF. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 1993;92: 288–296.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Plow, E.E. (2003). Platelet Adhesion. In: Lincoff, A.M. (eds) Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-376-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-376-7_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-408-1
Online ISBN: 978-1-59259-376-7
eBook Packages: Springer Book Archive